Viewing Study NCT00310440



Ignite Creation Date: 2024-05-05 @ 4:48 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00310440
Status: COMPLETED
Last Update Posted: 2020-03-12
First Post: 2006-04-03

Brief Title: An Assessment of P-15 Bone Putty in Anterior Cervical Fusion With Instrumentation
Sponsor: CeraPedics Inc
Organization: CeraPedics Inc

Study Overview

Official Title: An Assessment of P-15 Bone Putty in Anterior Cervical Fusion With Instrumentation
Status: COMPLETED
Status Verified Date: 2020-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of this trial is to evaluate if P-15 bone putty investigational device is not inferior in effectiveness and safety to local autologous bone control device when applied in instrumented anterior cervical discectomy and fusion ACDF with use of a structural allograft ring in patients with degenerative cervical disc disease
Detailed Description: Anterior Cervical Discectomy and Fusion ACDF is a common surgical treatment option for symptomatic degenerative cervical disk disease in patients who fail conservative treatment i-FACTOR bone graft is a unique anorganic bone mineral ABM and small peptide P-15 P-15 is a synthetic fifteen amino acid polypeptide that mimics the cell-binding domain of Type I human collagen and is responsible for osteogenic cell attachment via alpha2-beta1 integrins

This is randomized controlled multi-center prospective FDA IDE study conducted to assess the safety and effectiveness of i-FACTOR bone graft Cerapedics Inc Westminster CO in patients treated with single level ACDF Patients received i-FACTOR bone graft or local autologous bone inside a structural allograft

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None